Evidence map›Paper›PMID 26777774›Full record

Trial reportDrug and alcohol dependence2016

Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence.

Peter T Morgan, Gustavo A Angarita, Sofija Canavan, Brian Pittman, Lindsay Oberleitner, Robert T Malison, Vahid Mohsenin, Sarah Hodges, Caroline Easton, Sherry McKee and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 5 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 5 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Review
  9. The use ofFrontiers in cell and developmental biology · 2026
    Review
  10. Article
  11. Review
  12. Modafinil, an atypical CNS stimulant?Advances in pharmacology (San Diego, Calif.) · 2024
    Article
  13. Sleep-mediated regulation of reward circuits: implications in substance use disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Peter T MorganConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States. Electronic address: peter.morgan@yale.edu.
Gustavo A AngaritaConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Sofija CanavanConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Brian PittmanConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Lindsay OberleitnerConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Robert T MalisonConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Vahid MohseninSection of Pulmonary, Critical Care and Sleep Medicine, Yale Center for Sleep Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, United States.
Sarah HodgesConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Caroline EastonConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Sherry McKeeConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Andrew BessetteConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Erica ForseliusConnecticut Mental Health Center, Yale University Department of Psychiatry, 34 Park Street, New Haven, CT 06519, United States.
Yale University · USConnecticut Mental Health Center · US

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Modafinil, sleep architecture, and cocaine relapseR01DA011744 · NIDA · YALE UNIVERSITY · PI MORGAN, PETER T · 1999 to 2014
$4.4M
NCATS NIH HHS UL1 TR000142NIDA NIH HHS DA011744NIDA NIH HHS R01 DA011744
6 · The paper itself

Abstract

objectiveTo determine whether the increase in slow-wave sleep associated with modafinil treatment in chronic cocaine users mediates improved clinical outcomes.

method57 cocaine dependent participants were randomized to receive modafinil 400mg or placebo daily during a period of inpatient treatment followed by six weeks of outpatient treatment. Participants underwent polysomnographic sleep recording during inpatient treatment prior to and after starting modafinil. Outpatient treatment consisted of weekly cognitive behavioral therapy. Contingency management was used to promote participation in treatment and research demands, including thrice weekly visits during the outpatient phase for urine toxicology screens and other assessments. The primary clinical outcome was the percent of urine toxicology screens that were negative for cocaine.

resultsModafinil treatment was associated with a higher mean percentage (52% vs. 26%) of cocaine-free urine screens (p=0.02) and an increase in N3 sleep time (p=0.002). The change in N3 sleep time mediated the higher rate of cocaine-free urine screens. Modafinil treatment was also associated with more consecutive days abstinent during outpatient treatment, greater survival of abstinence, higher daily rates of abstinence, and less sleep degradation typically associated with abstinence from chronic cocaine use.

conclusionsMorning-dosed modafinil improves slow-wave sleep in abstinent cocaine users in the inpatient setting, and this effect is a statistical mediator of improved clinical outcomes associated with continued modafinil treatment. The high rates of abstinence achieved in this trial suggest that promoting healthy sleep physiology in an inpatient setting may be important in the effective treatment of cocaine dependence.

Indexed as

AdultBenzhydryl CompoundsCocaine-Related DisordersCognitive Behavioral TherapyCombined Modality TherapyFemaleHumansInpatientsMaleMiddle AgedModafinilOutpatientsSleepSleep Wake DisordersTreatment OutcomeWakefulness-Promoting AgentsBenzhydryl CompoundsModafinilWakefulness-Promoting AgentsCocaineModafinilSleepSlow-wave sleepTreatment

Identifiers

PMID26777774
PMCPMC4767553
OpenAlexW2222655682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.